Matsuyama Takahiro, Morita Takahiro, Horikiri Yuji, Yamahara Hiroshi, Yoshino Hiroyuki
Pharmaceutical Technology Department, CMC Research Laboratories, Tanabe Seiyaku Co., Ltd. Kashima 3-chome, Yodogawa-ku, Osaka, Japan.
J Control Release. 2007 Jul 16;120(1-2):88-94. doi: 10.1016/j.jconrel.2007.04.006. Epub 2007 Apr 18.
We examined the influence of filler species on the nasal absorbability of peptide drugs via a newly developed powdery formulation system containing N-acetyl-l-cysteine (NAC) as an absorption enhancer. Using salmon calcitonin (SCT) as the principal model drug, we tested the effects of various formulations with different powder materials as fillers on the nasal absorption of SCT in rats. An intranasal administration experiment revealed that the use of less wettable powders provided better nasal absorbability, and the highest absolute bioavailability (30.0% +/- 8.6%) was obtained when ethylcellulose was used as a filler. All these results were readily explicable in terms of our hypothetical enhancing mechanism. Furthermore, human parathyroid hormone and insulin were applied to this ethylcellulose formulation system, giving nasal bioavailabilities of 28.2% +/- 6.5% and 23.4% +/- 10.6%, respectively, thus suggesting that this formulation system is widely applicable to peptide drugs.
我们通过一种新开发的以N-乙酰-L-半胱氨酸(NAC)作为吸收促进剂的粉末制剂系统,研究了填充剂种类对肽类药物鼻腔吸收性的影响。以鲑鱼降钙素(SCT)作为主要模型药物,我们测试了以不同粉末材料作为填充剂的各种制剂对大鼠鼻腔吸收SCT的影响。鼻内给药实验表明,使用润湿性较小的粉末可提供更好的鼻腔吸收性,当使用乙基纤维素作为填充剂时,可获得最高的绝对生物利用度(30.0%±8.6%)。根据我们假设的增强机制,所有这些结果都很容易解释。此外,将人甲状旁腺激素和胰岛素应用于该乙基纤维素制剂系统,鼻腔生物利用度分别为28.2%±6.5%和23.4%±10.6%,因此表明该制剂系统广泛适用于肽类药物。